Studies show the drug, called Remdesivir, decreases the amount of time coronavirus patients spend in the hospital.
From
To
Wire
The treatment is monoclonal antibody therapy, and the antibodies come from people who have recovered from the novel coronavirus. Researchers then take the blood, select the most potent antibodies, and make them into a drug.